Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-041034

Chief Commercial Officer sold 17,000 shares at an average $191.69 ($3,258,736)

  • Chief Commercial Officer acquired 17,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CRUTCHFIELD BRADFORD · Chief Commercial Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-14 Exercise or conversion : show line 1 in the form +17,000 $1.16 $19,720 60,262 D
2021-06-14 Sale : show line 2 in the form −916 $189.03 $173,147 59,346 D
2021-06-14 Sale : show line 3 in the form −3,084 $190.01 $585,995 56,262 D
2021-06-14 Sale : show line 4 in the form −3,000 $191.16 $573,476 53,262 D
2021-06-14 Sale : show line 5 in the form −4,500 $192.12 $864,535 48,762 D
2021-06-14 Sale : show line 6 in the form −5,100 $192.97 $984,128 43,662 D
2021-06-14 Sale : show line 7 in the form −400 $193.64 $77,456 43,262 D
Open-market sales · 17,000 sh · avg $191.69 · $3,258,736

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-06-14 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −17,000 $1.16 2027-02-03 17,000 528,000 D
Loading xslF345X03/doc4.xml…